← Open Payments lookup

SARAH MCFERON: Open Payments

NPI 1902303183 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,771 in 69 payments from 10 companies in 2025. Trend: 2023 $1,548 · 2024 $1,443 · 2025 $1,771

Food & beverage: $1,771
CompanyPaymentsAmount
Madrigal Pharmaceuticals18$711
Gilead Sciences, Inc.16$378
ABBVIE INC.13$225
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$182
Ipsen Biopharmaceuticals, Inc6$121
Eisai Inc.3$88
Intercept Pharmaceuticals, Inc.1$19
Eton Pharmaceuticals, Inc.1$17
Intra-Sana Laboratories1$16
Braintree Laboratories, Inc.1$14

Products named: REZDIFFRA, MAVYRET, XIFAXAN, IQIRVO, Lenvima, OCALIVA, GALZIN, RELTONE 200 MG.

Industry payments across TX — which companies pay providers there.